B. Riley Raises Aspen Aerogels (NYSE:ASPN) Price Target to $30.00

Aspen Aerogels (NYSE:ASPN) had its price target boosted by B. Riley from $24.00 to $30.00 in a report issued on Friday, Benzinga reports. They currently have a buy rating on the construction company’s stock.

A number of other research analysts have also recently commented on ASPN. TheStreet raised shares of Aspen Aerogels from a d+ rating to a c- rating in a report on Wednesday, March 6th. Piper Sandler boosted their target price on shares of Aspen Aerogels from $20.00 to $29.00 and gave the stock an overweight rating in a research note on Friday. HC Wainwright increased their price target on Aspen Aerogels from $20.00 to $25.00 and gave the company a buy rating in a research note on Friday. Finally, Roth Mkm reaffirmed a buy rating and issued a $22.00 target price on shares of Aspen Aerogels in a report on Tuesday, April 30th. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels currently has a consensus rating of Moderate Buy and a consensus target price of $25.17.

Aspen Aerogels Stock Up 5.3 %

NYSE ASPN opened at $25.11 on Friday. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 1-year low of $5.32 and a 1-year high of $25.65. The company has a 50 day moving average of $16.72 and a 200-day moving average of $13.77. The company has a market cap of $1.93 billion, a price-to-earnings ratio of -57.07 and a beta of 1.97.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 6.54% and a negative net margin of 10.73%. The company had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. During the same quarter last year, the company posted ($0.20) EPS. On average, equities research analysts expect that Aspen Aerogels will post 0.03 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Aspen Aerogels by 71.4% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock worth $198,000 after buying an additional 9,601 shares during the period. Levin Capital Strategies L.P. lifted its stake in shares of Aspen Aerogels by 48.3% in the 3rd quarter. Levin Capital Strategies L.P. now owns 70,613 shares of the construction company’s stock valued at $607,000 after purchasing an additional 23,000 shares during the period. Principal Financial Group Inc. bought a new stake in shares of Aspen Aerogels during the 3rd quarter valued at about $449,000. Rice Hall James & Associates LLC grew its stake in Aspen Aerogels by 385.0% during the third quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock worth $5,359,000 after purchasing an additional 494,662 shares during the period. Finally, Mesirow Financial Investment Management Inc. bought a new stake in Aspen Aerogels in the third quarter worth approximately $334,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.